FILL/FINISH OUTSOURCED PHARMA CAPACITY UPDATE VIDEOS
Lonza Capacity Update January 2025: Fill/Finish
Discover how Lonza Biologics’ end-to-end Drug Product capabilities support the full lifecycle of biologics, seamlessly integrated with their extensive drug substance network across diverse modalities.
Lifecore Biomedical Capacity Update January 2025: Fill/Finish
Join Darren Hieber as he presents an overview of Lifecore Biomedical’s newly expanded capabilities, designed to meet the growing demands of innovative therapeutics.
Jubilant HollisterStier Capacity Update January 2025: Fill/Finish
From early development through small-scale production to full-scale global commercialization, our proven track record with international regulatory agencies underscores our ability to navigate complex requirements with precision.
FUJIFILM Diosynth Biotechnologies Capacity Update January 2025: Fill/Finish
Get an exclusive update on FDB’s current and future Drug Product and Finished Goods capabilities, and discover how their end-to-end CDMO services can support your next project.
Alcami Capacity Update January 2025: Fill/Finish
Equipped with advanced isolator and Restricted Access Barrier Systems (RABs) technologies, our aseptic filling facilities feature multiple filling lines capable of producing liquid and lyophilized vials as well as prefilled syringes.
Capacity Update January 2025: Fill/Finish
This presentation will showcase our extensive range of offerings, including our advanced high-speed, multi-purpose Fill/Finish line designed for vials, syringes, and cartridges.
SMC Ltd. Capacity Update October 2024: Fill/Finish
Partner with us to access the critical services that drive your success — supporting everything from technical and development batches to Phase 1 clinical trials and product launch.
PCI Pharma Services Capacity Update October 2024: Fill/Finish
Jeff Clement, Executive Director of Technical Sales Drug Product Development and Manufacturing, outlines our global sterile fill-finish and lyophilization capabilities, investments, and expansions.
Novartis Contract Manufacturing Services Capacity Update October 2024: Fill/Finish
Let us support your high-quality medicines with integrated offerings in mammalian drug substances and drug products, including our fill and finish services for vials, syringes, cartridges, and auto-injectors.
Lifecore Biomedical Services Capacity Update October 2024: Fill/Finish
Our injectables CDMO expertise can support your molecule, with a team skilled in complex formulations, over 20 commercial products, a 40+ year regulatory history, and a new isolator filler capacity.
Jubilant HollisterStier Services Capacity Update October 2024: Fill/Finish
Our full-service model enables us to collaborate with partners on sterile injectable projects, delivering quality products for both early clinical stages and large-scale commercial supply.
INCOG BioPharma Services Capacity Update October 2024: Fill/Finish
Learn about our new facility expansions, enhanced filling capacity, and advanced packaging capabilities that are designed to support and elevate your drug development projects.
Curia Capacity Update October 2024: Fill/Finish
Enhance your injectable projects with our expertise and expanded capacity to meet the demand for vials, pre-filled syringes, and cartridges from pre-clinical development to commercial launch.
Argonaut Manufacturing Services Capacity Update October 2024: Fill/Finish
Discover high-quality GMP manufacturing capabilities, featuring a state-of-the-art isolator-based filling platform and extensive fill-finish capacity for vials, syringes, and cartridges.
Alcami Capacity Update October 2024: Fill/Finish
Alcami provides sterile drug product fill-finish services, including formulation development, complex formulations, clinical manufacturing, batch scale-up, and commercial production.
Ajinomoto Bio-Pharma Capacity Update October 2024: Fill/Finish
Explore our exceptional injectable manufacturing capabilities, featuring our high-speed, multi-purpose fill-finish line for vials, syringes, and cartridges at our San Diego facility.
Ajinomoto Bio-Pharma Services Capacity Update July 2024: Fill/Finish
Review our range of offerings including our high speed, multi-purpose fill finish line for vials, syringes, and cartridges located in our manufacturing facilities in San Diego, CA.
FUJIFILM Diosynth Biotechnologies Capacity Update July 2024: Fill/Finish
Nadiyra Walker, Head of Drug Product and Finished Goods Manufacturing at FUJIFILM Diosynth Biotechnologies (FDB), presents an update on the state of FDB’s Drug Product and Finished Goods capabilities.
Singota Solutions Capacity Update July 2024: Fill/Finish
Review key services including drug formulation development, analytical testing, aseptic filling, pharmaceutical labeling and kitting, and supply chain management.
Mabion Capacity Update July 2024: Fill/Finish
Mabion, a biologics CDMO with end-to-end services focusing on recombinant proteins development and production, showcases new depyrogenation, fill finish vial capabilities, and CMC analytical proficiencies.
Simtra BioPharma Solutions Capacity Update July 2024: Fill/Finish
We currently have open capacity for development services as well as liquid vial projects at both manufacturing sites and can support rapid tech transfer depending on the complexity of the project.
Mycenax Capacity Update July 2024: Fill/Finish
Our capabilities include filling vials (liquid or lyophilized), pre-filled syringes (PFS), and cartridge product types, supporting batch sizes of 1,000 to 100,000 vials and up to 120 batches annually.
Capacity Update May 2024: Fill/Finish
INCOG has been designed and built to deliver better CDMO services in the injectable drug product space. Gain an overview and update of our expanding capabilities as we provide you with an inside look at our facility.
Ajinomoto Bio-Pharma Services Capacity Update May 2024: Fill/Finish
Explore our range of offerings, including our high-speed, multi-purpose fill finish line for vials, syringes, and cartridges located in our manufacturing facilities in San Diego, CA.
Alcami Capacity Update May 2024: Fill/Finish
Alcami offers sterile drug product fill finish services including formulation development, complex formulations, clinical manufacturing, batch scale-up, and commercial manufacturing.
Resilience Capacity Update May 2024: Fill/Finish
Resilience is a technology-focused biomanufacturing company dedicated to broadening access to complex medicines. Hear about how we can support manufacturing programs from clinical through commercial.
Novartis Contract Manufacturing Capacity Update May 2024: Fill/Finish
Learn more about our integrated offerings in mammalian drug substance and drug product. Our drug product (Fill & Finish) services cover vials (LivI, Lyo), syringes (PFS), Cartrdiges and Auto Injectors.
Pfizer CentreOne Capacity Update May 2024: Fill/Finish
Review Pfizer CentreOne’s overall sterile injectable drug substance capabilities, with a focus on our ability to help meet your complex sterile injectable needs.
PCI Pharma Services Capacity Update May 2024: Fill/Finish
Review our global sterile fill-finish and lyophilization capabilities, capacities, and how strategic investments allow us to meet the growing need for expert sterile development and manufacturing.
IDT Biologika Capacity Update May 2024: Fill/Finish
We are a sustainable partner in the commercial manufacturing of your liquid products. To advance the therapeutic and prophylactic therapies of clients, we have set up new state-of-the-art high-speed filling capacities.
Don't miss our next installment!
These conferences are ideal for professionals who have the authority to choose and manage CDMO relationships and need to secure capacity for their development or commercial programs.
How can we help?
Are you a supplier looking to present at our next event?